Lenee M Curtis, LPN | |
115 Butler Ln, Driggs, ID 83422-4816 | |
(208) 354-2717 | |
Not Available |
Full Name | Lenee M Curtis |
---|---|
Gender | Female |
Speciality | Licensed Practical Nurse |
Location | 115 Butler Ln, Driggs, Idaho |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1760706956 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164W00000X | Licensed Practical Nurse | PN-10939 (Idaho) | Primary |
Mailing Address | Practice Location Address |
---|---|
Lenee M Curtis, LPN 115 Butler Ln, Driggs, ID 83422-4816 Ph: (208) 354-2717 | Lenee M Curtis, LPN 115 Butler Ln, Driggs, ID 83422-4816 Ph: (208) 354-2717 |
News Archive
A team of UCLA researchers has received a $4.6 million grant from the National Institutes of Health to study ways to get HIV-positive men who have been released from Los Angeles County jails into medical care and on sustained treatment.
Researchers in the United States have developed "chimeric" vaccines that provided cross-protection against different strains of sarbecovirus in mice, including the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19).
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Halt Medical, Inc. announced today that it has received $15 million of financing to support commercialization of the Acessa System, a newly FDA cleared medical device to treat uterine fibroids.
› Verified 7 days ago